An interesting finding has been that NK activity in the peripheral blood of patients with breast cancer is lower than that in controls and also that the activity of NK cells in patients with HER2- cancers is significantly lower than that in patients with HER2+ tumors (Dewan et al., 2009). This evidence concerns the gene ERBB2 and breast cancer.